FMP
NASDAQ
22.16 USD
0.44 (1.99%)
Mr. Marc A. Stapley
Healthcare
Biotechnology
https://www.veracyte.com
NASDAQ
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to hel...
0001384101
US92337F1075
92337F107
6000 Shoreline Court
650 243 6300
US
815
Oct 30, 2013
0001384101
NASDAQ
Biotechnology
Healthcare
92337F107
US92337F1075
US
22.16
1.63
632.08k
1.66B
-
19.52-30.52
-5.58
-
-
-
-
-21.73
-
https://www.veracyte.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.